Analytical Quality by Design‐Based Reversed‐Phase High‐Performance Liquid Chromatography Method Development for the Simultaneous Determination of Ten Novel Anticancer Drugs and Establishment of Method Operable Design Region
SEPARATION SCIENCE PLUS · 2026-10 · 9 (10)
DOI: 10.1002/sscp.70335 ↗Kurz gefasst
Fachartikel in der Zeitschrift SEPARATION SCIENCE PLUS, online erschienen am 12.10.2026. Verfasst von Sai Ram Prasad Kollu und 2 weiteren Autor:innen. Die Arbeit nennt 62 Literaturangaben.
Abstract (Originalsprache)
An analytical quality by design‐based reversed‐phase high‐performance liquid chromatography method was systematically developed for the simultaneous determination of ten structurally diverse anticancer agents with the establishment of a method operable design region. The method development process was initiated by defining the analytical target profile, followed by risk assessment to identify potential critical method parameters. A Plackett–Burman design was employed as a screening tool to evaluate the influence of selected critical method parameters on critical analytical attributes. Statistically significant factors affecting chromatographic performance were identified and controlled to ensure method robustness. Chromatographic separation was achieved on a VDSpher PUR120 C18‐U (150 × 4.6 mm, 5 µm) column using a gradient elution consisting of 0.1% formic acid in water and 0.1% formic acid in acetonitrile: water (9:1, v/v). Based on the experimental findings, an appropriate operable region was defined to maintain acceptable resolution and system suitability. The developed method was validated in accordance with ICH Q2(R2) guidelines, demonstrating excellent linearity (r 2 > 0.999), accuracy, precision, specificity, robustness, limit of detection, and limit of quantification for all analytes. The environmental sustainability of the proposed method was further assessed using AGREE, AGREEprep, ComplexGAPI, MoGAPI, and ComplexMoGAPI, yielding favorable greenness scores. In addition, the principles of white analytical chemistry were evaluated using the multicolor analytical profile approach based on GEMAM, BAGI, RAPI, and VIGI, which resulted in scores of 69.3%, 85.0%, 65.0%, and 30.0%, respectively, with a final whiteness score of 62.3%. Comparative assessment with reported methods demonstrated a favorable overall greenness profile and the highest final whiteness score for the proposed method. The results confirm that the systematic quality‐driven strategy enables a reliable and reproducible chromatographic method suitable for routine pharmaceutical analysis.
Zitieren
APA
Kollu, S. R. P., Vuyyala, B., & Swain, D. (2026). Analytical Quality by Design‐Based Reversed‐Phase High‐Performance Liquid Chromatography Method Development for the Simultaneous Determination of Ten Novel Anticancer Drugs and Establishment of Method Operable Design Region. SEPARATION SCIENCE PLUS, 9(10). https://doi.org/10.1002/sscp.70335
Vancouver
Kollu SRP, Vuyyala B, Swain D. Analytical Quality by Design‐Based Reversed‐Phase High‐Performance Liquid Chromatography Method Development for the Simultaneous Determination of Ten Novel Anticancer Drugs and Establishment of Method Operable Design Region. SEPARATION SCIENCE PLUS. 2026;9(10). doi:10.1002/sscp.70335
BibTeX
@article{Kollu2026,
author = {Kollu, Sai Ram Prasad and Vuyyala, Bhuvaneshwari and Swain, Debasish},
title = {Analytical Quality by Design‐Based Reversed‐Phase High‐Performance Liquid Chromatography Method Development for the Simultaneous Determination of Ten Novel Anticancer Drugs and Establishment of Method Operable Design Region},
journal = {SEPARATION SCIENCE PLUS},
year = {2026},
volume = {9},
number = {10},
doi = {10.1002/sscp.70335}
}
EUVIMED